The Geometrical And Dose Accuracy Of The Cyberknife System In The .

1y ago
6 Views
3 Downloads
5.25 MB
90 Pages
Last View : 8d ago
Last Download : 3m ago
Upload by : Asher Boatman
Transcription

THE GEOMETRICAL AND DOSE ACCURACY OF THE CYBERKNIFESYSTEM IN THE TREATMENT OF BILE DUCT WITH THE USE OFMETALLIC STENTAnanta PandeyMSc thesisMaster's degree Program inMedical PhysicsUniversity of Eastern FinlandFaculty of Science and ForestryApplied Physics13.05.2021

University of Eastern Finland, Faculty of Science and ForestryDepartment of Applied Physics, Medical PhysicsAnanta Pandey: The geometrical and dose accuracy of the CyberKnife in the treatment of bile ductwith the use of metallic stent.Master’s thesis, 55 pagesSupervisors: Ph.D., Adjunct Professor, Chief Physicist Jan SeppalaMedical Physicist Jan-Erik PalmgrenMay 2021Key words: Radiation therapy, bile duct cancer, palliative treatment, CyberKnife, brachytherapy,gamma analysisAbstractBackground and Purpose: This study investigates the potential palliative treatment of bile ductcancer treatment through CyberKnife (CK) by examining the tracking capacity and accuracy to hitthe target during static and moving conditions. This study makes a comparison betweenbrachytherapy (BT) and CK treatment in the palliative treatment of bile duct cancer.Material and Methods: 3D printed phantoms rod along with Computerized Imaging ReferenceSystems, Incorporated (CIRS) phantom capable of resembling breathing motion were used forirradiating treatment plans (TPs) created through CK Multiplan treatment planning system (TPS)and BT Oncentra TPS. Stents were kept in between the phantom rods and fiducial markers wereused to track the motion of the rod. EBT3 radiochromic films were placed in between the rods tomeasure the dose. MyQA software was used for gamma analysis of the dose of TPS and measureddose through radiochromic films. The passing criteria in terms of dose difference (DD)/distanceto agreement (DTA) were 3%/3 mm and 4%/3 mm with gamma passing percentages of 90% and95% respectively. Average absolute dose difference and average dose differences were alsocalculated through MyQA software. 1 patient CT data was used for making TPs through MultiplanTPS and Oncentra TPS. The dose volume histogram (DVH) extracted from both TPS was used forcomparison of dose to organs at risk (OARs) and target volumes.Results: The measurement of CK dose in a stationary and moving condition of phantom whenirradiated with the same TP had the gamma passing rate of more than 99% in both the 3%/3 mmand 4%/3 mm criteria. The DVH analysis of CK and BT TPs showed that the dose to OARsthrough BT has less compared to CK. In the case of planning target volume (PTV) dose coverage,CK was better and dose to geometrical structures (structures overlapping the PTV with uniformdistance) was superior with CK in comparison to BT.Conclusions: CK can deliver a similar dose that of a stationary state to target in motion whenfiducial markers are used. CK could deliver a more precise dose to target volumes and BT wasbetter in sparing dose to OARs. CK can be an option for the palliative treatment of bile duct cancer.2

THDRLDRCyberKnifeBrachytherapyOrgan at riskPlanning target volumeDose volume histogramTreatment planTreatment planning systemOptical densityDose differenceDistance to agreementComputerized Imaging Reference Systems, IncorporatedStereotactic body radiation therapyStereotactic radiation surgeryComputed tomographyHigh dose rateLow dose rate3

ACKNOWLEDGEMENTSI am thankful for the opportunity given by the University of Eastern Finland, Department ofForestry and Science to study in the wonderful environment.Firstly, I would like to show my gratitude and thanks to my main supervisor Ph.D., AdjunctProfessor, Chief Physicist Jan Seppala. He gave me an opportunity to work in the advancedRadiotherapy Department and from which I could get the knowledge of the practicalimplementation of the laws of physics in radiotherapy. He has been the encouraging, helpful andguiding person throughout my thesis work. His valuable time and guidance during planning andexecution of the experimental works, using different software and equipment, and writing thethesis has been immense.I would like to thank my co-supervisor Senior Medical Physicist Jan-Erik Palmgren who guidedme with brachytherapy work and taught me to use different software used during the study. I wouldlike to thank Senior Medical Physicist Janne Heikkilä, Senior Medical Physicist Tuomas Viren,and other medical employees of the department who have helped and guided me whenever I wasconfused and asked for help during my thesis work in the Radiotherapy Department.4

Contents1 INTRODUCTION . 72 THE AIM OF THE STUDY . 83 THEORY . 93.1 TYPES OF BILE DUCT CANCER AND ITS DIAGNOSIS . 93.2 STENT . 103.3 BRACHYTHERAPY . 103.3.1 Brachytherapy dosimetry formalism . 113.3.2 HDR brachytherapy . 133.4 STEREOTACTIC BODY RADIATION THERAPY AND CYBERKNIFE . 143.5 MULTIPLAN: TREATMENT PLANNING SYSTEM OF CYBERKNIFE . 163.6 FILM DOSIMETRY . 184 MATERIALS AND METHODS . 214.1 PHANTOMS. 214.1.1 CIRS phantom . 214.1.2 3D printed phantoms . 224.2 TREATMENT PLANNING . 254.2.1 Computed Tomography imaging of the phantoms. 254.2.2 Contouring . 264.2.3 HDR Brachytherapy planning . 264.2.4 Multiplan treatment planning system for CyberKnife . 264.2.5 A Clinical Patient Case . 274.3 IRRADIATION OF TREATMENT PLANS . 274.3.1 Elekta linear accelerator . 274.3.2 CyberKnife . 284.3.3 Flexitron afterloader . 294.4 EBT3 FILMS AND FILM SCANNING . 294.4.1 EBT3 films . 294.4.2 Film scanning . 304.5 EVALUATING TOOLS . 314.5.1 MyQA . 314.5.2 Dose Volume Histogram . 335 RESULTS. 345.1 CALIBRATION CURVE USING EBT3 FILMS. 345.2 GAMMA ANALYSIS AND DOSE DIFFERENCE BETWEEN DOSE PLANES . 355

5.3. DOSE ANALYSIS OF BRACHYTHERAPY AND CYBERKNIFE TREATMENT PLAN INTHE BILE DUCT PATIENT EXAMPLE. 396 DISCUSSION . 436.1 ERRORS DURING STUDY . 436.1.1 Calibration curve error . 436.1.2 Alignment error in MyQA software. 446.1.3 Errors during brachytherapy gamma analysis . 456.2 CLINICAL SIGNIFICANCE OF THE RESULTS . 456.3 CHALLENGES AND FUTURE POSSIBILITY . 467 SUMMARY AND CONCLUSIONS . 47REFERENCES . 48Appendix . 56Appendix A: . 56Appendix B: Brachytherapy gamma analysis . 73Appendix C: Average dose difference and average absolute dose difference . 786

1 INTRODUCTIONCholangiocarcinoma (CCA) is a tumor that arises from the epithelial lining of the biliary tract. Thediagnosis of this type of cancer is difficult as the symptoms could be nonspecific, such as painlessjaundice, weight loss, or cholangitis. The cases are usually identified at the late stage of the disease.With these circumstances, generally, the treatment is poor and has a dismal prognosis. Thecomplete surgical resection is the only possibility for the cure and only a few patients are potentialcandidates for surgical resection. In such cases as well, the 5-year survival rate after surgery is 3040% for intrahepatic cancer and up to 50% for ductal cancers. In carefully selected cases,combining the different treatment modalities such as liver transplantation, systemic chemotherapy,and radiation therapy has exceeded 70% in 5-year survival rate [1,2].Mostly, the patient with CCA is identified late due to a lack of consistent biomarkers anddiagnostic tools for early detection of disease which makes the curative measures only possiblewith a small number of patients through surgical resection [3,4]. In the majority of cases due tothe advancement of cancer, palliative measures of treatment are performed to improve the qualityof life [3,5]. The aim of palliative treatment is to enhance the survival and quality of life of thepatient [6]. The combination of External Beam Radiation Therapy (EBRT), brachytherapy (BT),and chemotherapy has been used for palliative treatment [5,7]. BT can enhance local control,improve quality of life by prolonging patency of the biliary tract, and can facilitate the outflow ofbile [5]. Hypofractionation EBRT in the treatment of locally advanced bile duct cancer has beenreported to offer higher rates of local control for patients [8,9]. Stereotactic body radiation therapy(SBRT) using CyberKnife (CK) has been reported to offer low toxicity and higher local controlrates [10–13]. In Kuopio University Hospital, the bile duct radiation treatments are performed withBT.Our study is focused on the investigation of the feasibility of CK technology in the treatment ofbile duct cancer. The study can be a stepping tool to determine the feasibility of CK treatment inthe treatment of bile duct cancer and potentially be an option for the palliative treatment of bileduct cancer. In our study, phantoms were used which resemble the anatomy of the human thorax.Irradiations were limited to the phantoms which have anatomical structures simplified and not asheterogeneous as with the real patient. In addition to phantom studies, single patient data is usedto analyze dose to organs at risk (OARs) and target volumes through dose volume histogram(DVH) to make the comparison between CK and BT treatment plans (TPs).7

2 THE AIM OF THE STUDYIn Kuopio University Hospital, BT is currently being used for delivering localized dosedistribution to the target volume of interest in bile duct treatments. BT can be only used in caseswhere the target is well localized and comparatively small. In some complicated geometricalstructures of the treatment area, the uniform dose delivery becomes challenging through BTtreatments. This study aims to1) investigate the CK tracking capability and accuracy in delivering high doses in static andmoving conditions.2) compare HDR BT with CK treatment delivery dose distributions.8

3 THEORY3.1 TYPES OF BILE DUCT CANCER AND ITS DIAGNOSISCCA can be divided into intrahepatic cholangiocarcinoma (IHC), perihilar cholangiocarcinoma(PHC), and distal CCA. Most of the clinical cases are related to PHC. PHC includes tumors thatinvolve or are in near proximity to the bile duct. The most commonly used staging system forevaluating PHC was given by the Bismuth-Corlette system [14,15]. In this system, the lesions areclassified as type I, type II, type III (IIIa, IIIb), and type IV. Type I lesion tumors consist of only acommon hepatic duct below the confluence of the left and right hepatic duct. Type II consists ofhepatic bile duct confluence but does not involve above the confluence. Type III consisting ofbiliary confluence and left hepatic only is defined as IIIa and involving right hepatic only withbiliary confluence is defined as type IIIb. Type IV involves biliary confluence and both hepaticducts [1,15]. Figure 3.1 shows the detailed information of the stages.Figure 3.1: Figure showing classification from the Bismuth-Corlette [1,15].The commonly used imaging modalities are cross-sectional computed tomography (CT), magneticresonance imaging (MRI), cholangiography with magnetic resonance cholangiopancreatography,endoscopic retrograde cholangiography, ultrasound (US), and positron emission tomography(PET) for the diagnosis and assessment of tumor staging. One or a combination of differentimaging modalities can be performed according to the requirement for making a treatment9

decision. However, there are some challenges regarding the diagnosis of CCA. The misleadingfactors such as atypical imaging features in some patients, missing the tumor when developed inthe background of predisposing disease, benign and malignant lesions that have similar imagingfeatures as CCA. Therefore, a suitable imaging module with careful image analysis is necessaryfor the proper diagnosis of CCA [16,17].3.2 STENTIn our study, we are using a self-expanding metallic stent (SEMS) with BT and with EBRT. Thestent is a hollow tube that is implanted into anatomical locations, typically in vessels and urologicalor digestive tracts. The stent is made of plastic or metal. Mostly, plastic stents are made ofpolyethylene, Teflon, or polyurethane. All biliary SEMSs are constructed with metal alloys; eithermaking mesh by cutting from a metal cylinder or metal wires are braided [18]. Plastic stents andSEMS efficiency are similar in the short-term result in case of clinical success, morbidity,mortality, and improvement in the quality of life. Whereas in long-term efficacy, SEMS have alower risk of biliary obstruction in comparison to the single plastic stent [19]. In cases of latecomplication, the complication occurs mostly by stent dysfunction, which is approximately twiceas frequent with the plastic stent in comparison to SEMS [19]. Plastic stents are potentiallyretrieval, inexpensive and repositioning is possible as many times as required. However, migrationand interference with mucociliary clearance is the prime problem. Placement of a plastic stentusually requires rigid bronchoscopy and general anesthesia [20]. On the other hand, the metallicstent is technically easier to insert, has comparatively less problem with migration, and has a morefavorable internal to external diameter. Another aspect of the metallic stent is that it often embedsin the mucosa, which makes it difficult to remove [20].3.3 BRACHYTHERAPYBT is a type of internal beam radiotherapy in which a radiation source is placed inside or near tovolume of interest (tumor). The placement of radioactive sources can be done permanently ortemporarily depending upon the radiation source activity, half-life, decay process, photon energyreleased, treatment area, and treatment requirement. Some of the radioisotopes used in BT with10

their half-life, decay process, and photon energy are shown in Table 1.1. Permanent implant BTcan be applied using isotopes such as cesium-131 (131Cs), Iodine-125 (125I), or palladium-103(103Pd) that emit low-energy photons when they decay and can be placed permanently withoutcreating radiation hazard for medical staff or the general public. The temporary implant usesisotopes that release high energy photons such as cesium-137 (137Cs), iridium-192 (192Ir), andcobalt-60 (60Co). The process is implemented in an environment with adequate shielding andsafety measures for staff and the general public. A temporary implant can be a low dose rate(LDR), pulsed dose rate (PDR), or high dose rate (HDR) [21].IsotopeHalf-LifeDecay ProcessPhoton Energy (KeV2261,600 yearsα8305.26 yearsβ1250Ra60Co125I59.4 dayse-capture35103Pd17 dayse-capture21131Cs9.7 dayse-capture30137Cs30 yearsβ662192Ir74.3 daysβ380Table 1.1: General characteristics of radioisotopes used in BT [21].In BT, the dose is better localized to the target volume of interest but can be performed only in thewell localized and relatively small tumors which accounts for about 10-20% of the radiotherapypatients in a typical radiotherapy department [22].3.3.1 Brachytherapy dosimetry formalismOlder calculation formalism for BT dosimetry was based on apparent activity (Aapp), equivalentmass of radium, exposure-rate constants, and tissue-attenuation coefficient which did notaccommodate the factors such as source-to-source differences in encapsulation or internalconstruction. The American Association of Physicists in Medicine (AAPM) Task Group No. 43gave a protocol (TG-43) for the dose calculation in BT in 1995 and was updated in 2004. Theintroduction of TG-43 has resulted in the standardization of dose calculation and dose-ratedistribution. The general formalism for the two-dimensional (2D) dose-rate equation given by TG43 is given below with the descriptions of parameters in the formalism [23].11

𝐺 (𝑟,𝜃)Ḋ(𝑟, 𝜃) 𝑆𝐾 𝛬 𝐺 𝐿(𝑟𝐿0 ,𝜃0 ) 𝑔𝐿 (𝑟) 𝐹(𝑟, 𝜃) ,(1)where r is the distance from the center of the active source, ro is reference distance and kept as 1cm, θ denotes the polar angle specifying the point of interest P(r, θ), relative to the sourcelongitudinal axis and θ0 is the reference angle which defines the source transverse plane and valueis 90 as shown in Figure 3.2 [23]. The different parameters used in the equation are describedbelow.Figure 3.2: Figure illustrating BT coordinate system for dosimetry calculation [23].Air-kerma strength (SK): Air kerma strength is the air kerma rate (K̇𝛿) in a vacuum where thephoton attenuation and scattering in any medium are not considered. It has a unit of µGym 2 h-1.Mathematically, it can be represented as,𝑆𝐾 𝐾̇𝛿 (𝑑)𝑑2 ,where d is the distance from the center of the source to the point of K̇𝛿 (d) [23]Dose rate constant (𝛬): It is the ratio of dose rate at reference point per air-kerma strength.Mathematically, it can be written as,𝛬 Ḋ(𝑟0 ,𝜃0 )𝑆𝐾,The dose rate constant can be determined using the Monte Carlo calculation method [24].Geometrical function (G): This function is used for inverse square-law correction and does nottake scattering and attenuation into account. It helps to improve the accuracy of the dose rate12

estimation. Following mathematical expression is used for approximation in the point and linesource.𝐺𝑃 (𝑟, 𝜃) 𝑟 2 for point-source approximation,𝛽𝐺𝐿 (𝑟, 𝜃) if 𝜃 0 {𝐿𝑟 sin 𝜃2(𝑟 2 𝐿 /4) 1 if 𝜃 0 for line source approximation.Where β is the angle as shown in Figure 3.2 [23].Radial dose function (𝑔𝑋 (𝑟)): The photon attenuation and scattering during the process cause thefall in the dose level. This parameter in the formalism takes account into those falls in doses onthe transverse plane.Ḋ(𝑟,𝜃0 ) 𝐺𝑋 (𝑟0 𝜃0 )0 ,𝜃0 ) 𝐺𝑋 (𝑟,𝜃0 )𝑔𝑋 (𝑟) Ḋ(𝑟,where X is the radial dose function and geometry function [23].2D Anisotropy Function F (r, θ): It is defined asḊ(𝑟,𝜃) 𝐺𝐿 (𝑟,𝜃0 )0 ) 𝐺𝐿 (𝑟,𝜃)𝐹(𝑟, 𝜃) Ḋ(𝑟,𝜃.It describes the effects of anisotropic photon attenuation as a function of polar angle relative tothe transverse plane [23,24].3.3.2 HDR brachytherapyHDR BT is a widely used mode of BT. It delivers a dose of 12 Gy/hour which makes it possibleto deliver the desired high dose in a short period of time. It is generally performed in the outpatientsetting [25]. The clinical outcome of HDR and LDR BT provides relatively equivalent treatmentin terms of survival in cervical cancer, gastrointestinal and genitourinary toxicity [25,26]. Themajor advantage of HDR is short treatment time which allows outpatient treatment, the radiationexposure to staff and the general public can be reduced near to null, consistency and reproducibleapplicator positioning, and the ability to optimize dosing to normal tissues [25,27]. Usually, HDRis performed using 192Ir isotope which has a half-life of 74 days. The activity of the new 192Ir sourceis generally around 10 Ci and the air kerma strength at the distance of 1 m (reference air kermarate) is 1.1337*10-5 Gy.m2.s-1 [28,29]. 192Ir isotope is a popular radiation source for HDR because13

of its high specific activity and high neutron cross-section [24]. In a year, the 192Ir source has tobe replaced 3 to 4 times to avoid prolonging the treatments [28]. HDR BT for the treatment ofperihilar cholangiocarcinoma has been used widely and has shown a positive impact on thetreatment outcome [5,30,31].3.4 STEREOTACTIC BODY RADIATION THERAPY AND CYBERKNIFEConventional radiotherapy uses 1.8-2 Gy/fraction for the radiotherapy treatments. On the otherhand, SBRT uses a hypofractionated schedule or a single fraction with a high doses [32]. Highradiation doses of SBRT kills the tumor not only by directly damaging DNA but also by affectingthe adventitia, most notably by causing vascular damage which increases the tumor hypoxia andinduces secondary tumor cell death. The effect on vasculature is more dominant with fractionaldoses of 8 to 12 Gy or higher. The direct tumor cell death and indirect tumor cell death due tovascular dysfunction after high dose irradiation cause a large number of tumor antigens and variousimmune factors which eventually elevates anticancer immunity. This radiobiological phenomenonis an important aspect of SBRT [33–35].In SBRT, the steep dose gradient is created by spreading out the radiation dose over a large surfacearea. When incoming photon beams are entering the patient, they are widely spread, and theintensity of the individual radiation beam is relatively low which causes minimal damage to normaltissue distant from the focus point. However, the total intensity in the desired target is high. Withthe development in the imaging and image guidance technology, the precise and accuratelocalization of OARs and target volume can be achieved, and thus the treatment margins can beminimized. The higher doses of radiation can be delivered with small field sizes by applying theprinciples of spreading out the energy, and precise and accurate localization [36]. Small volumesof the healthy organ can tolerate much higher radiation doses without injury than large volumes ofthe same organ which helps operate SBRT [34,35].CK consist of linear accelerator, robotic manipulator, imaging system and treatment couch. Thelinear accelerator mounted on a robotic manipulator is capable of delivering non-isocentric andnon-coplanar treatment beams. High accuracy of treatment beam alignment and delivery isobtained through an X-ray image guidance system, a robotic manipulator, frequent image guidanceand alignment correction throughout each treatment fraction. These features help to minimizeclinical target volume (CTV) to planning target volume (PTV) margin. High dose conformality14

and steep dose gradients in all directions are acquired through robotic manipulator, variablecollimator, and plan optimization algorithms [37].Radiosurgery treatments require the system to produce high conformality, steep dose gradients,and motion tracking of the treatment area. These conditions are met by different features andinstruments to build in a CK. The robotic manipulator uses multiple numbers of non-isocentric andnon-coplanar beams which are individually targeted at a unique point within the patient withoutthe need to reposition the patient for each beam, The IrisTM Variable Aperture collimator canproduce multiple field sizes which combine with each treatment to create complex dosedistribution from a set of independently targeted and sized beams. Ideal beam weight, beamdirection, and beam sizes are selected through inverse plan optimization. The image guidancesystem frequently tracks the patient, organ, and target movement. Information obtained from itguide the system to automatically correct beam targeting without hindering treatment [37–39]. Thelinear accelerator of the CK produces flattening filter free (FFF) beams. FFF beams help to providehigh dose rate, reduction in out-of-field dose, and decrease head scattering [40–42]. Studies relatedto clinical cases using FFF beams for treatment planning and dose delivery have demonstratedsuitability and superiority over flattening filter (FF) beams [42].15

Figure 3.3: The CyberKnife treatment machine of Kuopio University Hospital.CK (Accuray inc.) is designed for stereotactic radiotherapy treatments (SRT). The accuracy of CKis in sub-millimeter in tracking target and tumor position compared to accuracy of millimeter withconventional linear accelerator [43].3.5 MULTIPLAN: TREATMENT PLANNING SYSTEM OF CYBERKNIFEThe Multiplan treatment planning system (Accuray Inc.) (TPS) of CK in the Kuopio UniversityHospital consists of a Monte Carlo (MC) dose calculation algorithm and ray tracing algorithm.Accuracy of dose calculation is vital in the TPS. The over approximation and under approximationof the calculated dose leads to the decrease and increase in actual irradiation dose, respectively[44,45]. In the homogeneous medium, almost same result is obtained from all the calculationalgorithms. But in case of a tumor is in an inhomogeneous medium, the precise calculation of dosedistribution in the tumor and the surrounding medium is vital, significantly in radiosurgery because16

of the use of hypofractionation schedule [46]. An algorithm such as ray tracing uses an equivalentpath-length algorithm (EPL) which consistently underestimates the penumbra width in low densityregions and overestimates the dose to PTV [47,48]. The EPL based algorithm merely accounts fordecreasing attenuation of the primary photon beams in low density such as lung tissue, whileincreased electron range is not accounted [47].MC dose calculation is the most accurate dose calculation algorithm for radiation therapy treatmentplanning and dosimetry verification [47,49]. The MC method is a stochastic technique that usesrandom numbers and probability statistics to investigate problems. MC methods involve theprocess to get an approximation of the answer to the problem by performing many simulations(histories) using random numbers and probability distribution. It uses random numbers throughoutthe simulation process [50]. The MC technique for the simulation of the transport of electrons andphotons is performed by using knowledge of the probability distributions of the individualinteractions of electrons and photons in materials to simulate the random trajectories of individualparticles. The tracking of physical quantities of interest for a large number of histories is done toprovide the required information about the average quantities [51,52]. When applying this conceptin d

THE GEOMETRICAL AND DOSE ACCURACY OF THE CYBERKNIFE SYSTEM IN THE TREATMENT OF BILE DUCT WITH THE USE OF METALLIC STENT . evaluating PHC was given by the Bismuth-Corlette system [14,15]. In this system, the lesions are . Therefore, a suitable imaging module with careful image analysis is necessary for the proper diagnosis of CCA [16,17].

Related Documents:

Silat is a combative art of self-defense and survival rooted from Matay archipelago. It was traced at thé early of Langkasuka Kingdom (2nd century CE) till thé reign of Melaka (Malaysia) Sultanate era (13th century). Silat has now evolved to become part of social culture and tradition with thé appearance of a fine physical and spiritual .

May 02, 2018 · D. Program Evaluation ͟The organization has provided a description of the framework for how each program will be evaluated. The framework should include all the elements below: ͟The evaluation methods are cost-effective for the organization ͟Quantitative and qualitative data is being collected (at Basics tier, data collection must have begun)

̶The leading indicator of employee engagement is based on the quality of the relationship between employee and supervisor Empower your managers! ̶Help them understand the impact on the organization ̶Share important changes, plan options, tasks, and deadlines ̶Provide key messages and talking points ̶Prepare them to answer employee questions

Dr. Sunita Bharatwal** Dr. Pawan Garga*** Abstract Customer satisfaction is derived from thè functionalities and values, a product or Service can provide. The current study aims to segregate thè dimensions of ordine Service quality and gather insights on its impact on web shopping. The trends of purchases have

On an exceptional basis, Member States may request UNESCO to provide thé candidates with access to thé platform so they can complète thé form by themselves. Thèse requests must be addressed to esd rize unesco. or by 15 A ril 2021 UNESCO will provide thé nomineewith accessto thé platform via their émail address.

Chính Văn.- Còn đức Thế tôn thì tuệ giác cực kỳ trong sạch 8: hiện hành bất nhị 9, đạt đến vô tướng 10, đứng vào chỗ đứng của các đức Thế tôn 11, thể hiện tính bình đẳng của các Ngài, đến chỗ không còn chướng ngại 12, giáo pháp không thể khuynh đảo, tâm thức không bị cản trở, cái được

dose by dividing half of the total daily injected pre-mixed insulin dose equally among the three meals of the day. Convert each estimated injected mealtime dose to an appropriate AFREZZA dose using Figure 1 Administer half of the total daily injected pre-mixed dose as an injected basal insulin dose. Figure 1. Mealtime AFREZZA Dose Conversion Table

Integrated Dose Management Integrated Optimized Workflow to Minimize Dose Scan Planning Real-time dose display Dose displayed on console prior to exam CTDI phantom size . . Automated Increase clinical workflow Dose Reduction Simplified . 7/22/2014 9 Adaptive Iterative Dose Reduction (AIDR) 3D Scanner Model Projection Noise